相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)
F. Conforti et al.
ESMO OPEN (2021)
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Thymic epithelial tumors: From biology to treatment
Fabio Conforti et al.
CANCER TREATMENT REVIEWS (2020)
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial
Jun Sato et al.
LANCET ONCOLOGY (2020)
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study
Yuki Katsuya et al.
EUROPEAN JOURNAL OF CANCER (2019)
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone et al.
LANCET ONCOLOGY (2018)
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)
Martina Imbimbo et al.
CANCER TREATMENT REVIEWS (2018)
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
Anish Thomas et al.
LANCET ONCOLOGY (2015)
High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
Roberta Sanfilippo et al.
CLINICAL SARCOMA RESEARCH (2014)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
分享论文
